Cafepharma Today

April 26 2024 - Why the obesity drug market is about to get a lot more crowded
Why the obesity drug market is about to get a lot more crowded
Pfizer hemophilia gene therapy arrives in US to uncertain future
AbbVie lifts profit forecast after Skyrizi sales beat expectations
Walgreens rolls out gene, cell therapy services
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Here's Why Teva's Latest Report Might Worry You
Motley Fool
Friday, August 5, 2011 - 10:23am
tags:
Teva Pharmaceuticals
Momenta Pharmaceuticals - Earnings
Yahoo/InvestorsBusinessDaily
Friday, August 5, 2011 - 10:22am
tags:
Momenta, earnings
Somaxon's Bore of a Quarter
Motley Fool
Friday, August 5, 2011 - 10:13am
tags:
Somaxon, earnings
How Many Doctors Won’t Accept Samples?
Pharmalot
Friday, August 5, 2011 - 10:10am
tags:
physicians, samples
Merck cuts put pharma on top of layoffs list
Fierce Pharma
Thursday, August 4, 2011 - 4:59pm
tags:
layoffs, Merck
Dendreon Falls Most Ever After Pulling Sales Forecast on Cancer Therapy
Bloomberg
Thursday, August 4, 2011 - 4:36pm
tags:
Provenge, Dendreon, prostate cancer
Endo Pharmaceuticals Earnings Preview
Motley Fool
Thursday, August 4, 2011 - 4:35pm
tags:
Endo, earnings
Dendreon CEO Dumped $1M in Stock Before Withdrawing Revenue Guidance
BNET Pharma
Thursday, August 4, 2011 - 1:09pm
tags:
Dendreon, Provenge, Pharma CEOs, Mitchell Gold
Vanda Pharmaceuticals reports loss
Bizjournals.com
Thursday, August 4, 2011 - 1:06pm
tags:
earnings, Vanda
Multitalented Botox could get $500M off bladder indication
Fierce Pharma
Thursday, August 4, 2011 - 10:59am
tags:
Botox, Allergan, overactive bladder
Dendreon's Blowup Spreads Across Biotech
TheStreet.com
Thursday, August 4, 2011 - 10:57am
tags:
Dendreon, Provenge, InterMune, Human Genome Sciences, Seattle Genetics, Regeneron, Savient
YM BioSciences JAK Inhibitor CYT387 Shown Active in Multiple Myeloma
Yahoo
Thursday, August 4, 2011 - 10:56am
tags:
JAK inhibitors, CYT387, Multiple Myeloma, YM BioSciences
MAP Pharmaceuticals Reports Second Quarter of 2011 Financial Results
Yahoo
Thursday, August 4, 2011 - 10:26am
tags:
MAP Pharmaceuticals, earnings
Pain Therapeutics Reports Q2 2011 Financial Results
earnings
Thursday, August 4, 2011 - 10:25am
tags:
Pain Therapeutics
Merck, Novartis top drug-approval rankings
Fierce Pharma
Thursday, August 4, 2011 - 10:20am
tags:
drug approvals, Merck, Novartis
Sangamo: An Introduction to Its Gene Altering Technology
Seeking Alpha
Thursday, August 4, 2011 - 10:19am
tags:
Sangamo BioSciences
7 High-Yield, Large-Cap Pharmas to Consider
Seeking Alpha
Thursday, August 4, 2011 - 10:18am
tags:
AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GSK, Merck, Pfizer, Sanofi
Insmed, The Definition of Risk
Seeking Alpha
Thursday, August 4, 2011 - 9:59am
tags:
Insmed
Roche asthma drug shows promise in mid-stage trial
Reuters
Thursday, August 4, 2011 - 9:57am
tags:
Roche, asthma, lebrikizumab
First Orphan Launch a Challenge for AstraZeneca
PharmExec
Thursday, August 4, 2011 - 9:55am
tags:
AstraZeneca, Caprelsa, vandetanib, thyroid cancer, Zactima

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers
Drug Channels
The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels

Latest Jobs

Account Executive - Hospice
Kansas City, MO, 64190
Agape Care Group
Area Manager-Specialty Mid-South
Fields, OR, 97710
CSL Behring
Account Executive - Hospice
Garden City, MO, 64747
Agape Care Group
Account Executive - Hospice
Holden, MO, 64040
Agape Care Group
Account Executive - Hospice
Harrisonville, MO, 64701
Agape Care Group
Account Executive - Hospice
Freeman, MO, 64746
Agape Care Group
Account Executive - Hospice
Higginsville, MO, 64037
Agape Care Group
Area Manager, Immunology West
Coffeyville, KS, 67337
CSL Behring
Area Manager-Immunology Southeast
Fields, OR, 97710
CSL Behring
Area Manager-Specialty, Delaware Valley
Fields, OR, 97710
CSL Behring
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information